Rigel Pharmaceuticals

Rigel Announces Pricing Of Common Stock Offering
Rigel Announces Pricing Of Common Stock Offering
CP Wire
Rigel Pharmaceuticals
stock offering
Flag link:
Rigel Announces Pricing Of Common Stock Offering
Rigel Pharmaceuticals
Flag link:
Rigel Proposes Stock Offering on Heels of Tavalisse Approval
Rigel Proposes Stock Offering on Heels of Tavalisse Approval
CP Wire
Rigel Pharmaceuticals
stock offering
Tavalisse
Flag link:
Rigel Proposes Stock Offering on Heels of Tavalisse Approval
Rigel Pharmaceuticals
Flag link:
FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults
FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults
CP Wire
Rigel Pharmaceuticals
Tavalisse
chronic immune thrombocytopenia
FDA
Flag link:
FDA Approves First in Class TAVALISSE for Chronic Immune Thrombocytopenia (ITP) in Adults
Rigel Pharmaceuticals
Tavalisse
chronic immune thrombocytopenia
Flag link:
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Flag link:
Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers
Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers
Bizjournals.com
Rigel Pharmaceuticals
Bristol-Myers Squibb
Flag link:
Rigel experimental eye drug fails mid-stage study
Rigel experimental eye drug fails mid-stage study
Yahoo/Reuters
Rigel Pharmaceuticals
R348
dry eye disease
Flag link:
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Yahoo/Fly on the Wall
fostamatinib
Rigel Pharmaceuticals
ITP
Flag link:
This Week in Biotech: Put It in Print
This Week in Biotech: Put It in Print
Motley Fool
Endo
Aveed
Rigel Pharmaceuticals
R118
Sangamo BioSciences
SB-728-T
NewLink Genetics
Xoma
gevokizumab
Flag link:
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
24/7 Wall St
Array Biopharma
Biodel
Galena Biopharma
Novavax
Protalix BioTherapeutics
Rigel Pharmaceuticals
Synta Pharmaceuticals
Zogenix
Flag link:
Rigel to drop skin disease drug after trial failure
Rigel to drop skin disease drug after trial failure
Yahoo/Reuters
Rigel Pharmaceuticals
discoid lupus
R333
Flag link:
Rigel Pharma Trims Workforce
Rigel Pharma Trims Workforce
Yahoo/Zacks
layoffs
Rigel Pharmaceuticals
Flag link:
Rigel Pharma Narrows Q2 Loss
Rigel Pharma Narrows Q2 Loss
Yahoo/AP
earnings
Rigel Pharmaceuticals
Flag link:
Is Big Pharma Learning From Its Late Stage R&D Setbacks?
Is Big Pharma Learning From Its Late Stage R&D Setbacks?
Forbes
R&D
Big Pharma
AstraZeneca
Rigel Pharmaceuticals
Flag link:
3 Drug Catalysts to Watch in 2013
3 Drug Catalysts to Watch in 2013
Motley Fool
MannKind
Merck
Pfizer
Sanofi
Rigel Pharmaceuticals
suvorexant
insomnia
diabetes
Afrezza
fostamatinib
rheumatoid arthritis
Flag link:
Rigel Pharmaceuticals Becomes Oversold (RIGL)
Rigel Pharmaceuticals Becomes Oversold (RIGL)
The Street
Rigel Pharmaceuticals
Flag link:
[video]3 Biggest Biotech Crashes in April
[video]3 Biggest Biotech Crashes in April
Motley Fool
Dyax
Rigel Pharmaceuticals
Sarepta
AstraZeneca
Flag link:
This Week in Biotech
This Week in Biotech
Motley Fool
JNJ
Optimer
Biogen
Merck
Cubist Pharmaceuticals
AstraZeneca
Rigel Pharmaceuticals
AbbVie
Pfizer
Flag link:

Pages